These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22833866)

  • 1. Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.
    Vialpando M; Martens JA; Van den Mooter G
    Ther Deliv; 2011 Aug; 2(8):1079-91. PubMed ID: 22833866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
    Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
    J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
    Pattnaik S; Pathak K
    Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
    Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
    Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
    McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
    Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release.
    Vialpando M; Aerts A; Persoons J; Martens J; Van Den Mooter G
    J Pharm Sci; 2011 Aug; 100(8):3411-3420. PubMed ID: 21387318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of solvent selection on drug loading and amorphisation in mesoporous silica particles.
    Šoltys M; Kovačík P; Dammer O; Beránek J; Štěpánek F
    Int J Pharm; 2019 Jan; 555():19-27. PubMed ID: 30395956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2020 Sep; 17(9):3435-3446. PubMed ID: 32790416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
    Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
    Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D; Sailaja Chirravuri SV; Shastri NR
    Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous materials and nanocrystals for enhancing the dissolution behavior of poorly water-soluble drugs.
    Santos HA; Peltonen L; Limnell T; Hirvonen J
    Curr Pharm Biotechnol; 2013; 14(10):926-38. PubMed ID: 24372243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
    Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
    J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquisolid systems and aspects influencing their research and development.
    Vraníková B; Gajdziok J
    Acta Pharm; 2013 Dec; 63(4):447-65. PubMed ID: 24451071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles.
    Limnell T; Heikkilä T; Santos HA; Sistonen S; Hellstén S; Laaksonen T; Peltonen L; Kumar N; Murzin DY; Louhi-Kultanen M; Salonen J; Hirvonen J; Lehto VP
    Int J Pharm; 2011 Sep; 416(1):242-51. PubMed ID: 21763766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous systems for poorly soluble drugs.
    Xu W; Riikonen J; Lehto VP
    Int J Pharm; 2013 Aug; 453(1):181-97. PubMed ID: 22990124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.
    Baumgartner A; Planinšek O
    Eur J Pharm Sci; 2021 Dec; 167():106015. PubMed ID: 34547382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.